Amylyx Pharmaceuticals, Inc. (AMLX) Operating cash flow 2021–2025
Amylyx Pharmaceuticals, Inc. (AMLX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$123.3MFY2025 · since FY2021: -$74.8M → -$123.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$123.3M | +26.4% |
| FY2024 | -$167.6M | -1506.6% |
| FY2023 | $11.9M | +106.6% |
| FY2022 | -$179.9M | -140.5% |
| FY2021 | -$74.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice